SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-11-209915
Filing Date
2011-08-04
Accepted
2011-08-04 13:22:33
Documents
3
Period of Report
2011-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 1 d8ka.htm 8-K/A 15846
2 CORRECTED PRESS RELEASE dex991.htm EX-99.1 63371
3 GRAPHIC g217075ex99_1pg001.jpg GRAPHIC 8313
  Complete submission text file 0001193125-11-209915.txt   91993
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-23186 | Film No.: 111009805
SIC: 2836 Biological Products, (No Diagnostic Substances)